Acorda Therapeutics Inc.

NASDAQ: ACOR · Real-Time Price · USD
0.66
-0.21 (-24.14%)
At close: Apr 03, 2024, 3:59 PM

Acorda Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-252.85M -65.92M -103.95M
Depreciation & Amortization
31.67M 32.81M 33.95M
Stock-Based Compensation
478K 1.49M 3M
Other Working Capital
-4.88M 676K 12.78M
Other Non-Cash Items
260.73M -21.68M 5.91M
Deferred Income Tax
-43.18M 30.67M -5.19M
Change in Working Capital
-10.83M 1.7M 24.93M
Operating Cash Flow
-13.98M -20.92M -41.35M
Capital Expenditures
-264K -136K -191K
Cash Acquisitions
n/a n/a 73.97M
Purchase of Investments
n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a
Other Investing Acitivies
n/a n/a 73.94M
Investing Cash Flow
-264K -136K 73.78M
Debt Repayment
n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
n/a n/a -69.66M
Financial Cash Flow
n/a n/a -69.66M
Net Cash Flow
-14.06M -20.55M -37.67M
Free Cash Flow
-14.25M -21.06M -41.54M